191 related articles for article (PubMed ID: 37115456)
21. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.
Yang X; Zhang XF; Lu X; Jia HL; Liang L; Dong QZ; Ye QH; Qin LX
Hepatology; 2014 May; 59(5):1874-85. PubMed ID: 24259426
[TBL] [Abstract][Full Text] [Related]
22. Exosome-mediated circTTLL5 transfer promotes hepatocellular carcinoma malignant progression through miR-136-5p/KIAA1522 axis.
Liu C; Ren C; Guo L; Yang C; Yu Q
Pathol Res Pract; 2023 Jan; 241():154276. PubMed ID: 36528986
[TBL] [Abstract][Full Text] [Related]
23. Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma.
Wang ZF; Liao F; Wu H; Dai J
J Exp Clin Cancer Res; 2019 May; 38(1):201. PubMed ID: 31101062
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of miR-4669 Enhances Tumor Aggressiveness and Generates an Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma: Its Clinical Value as a Predictive Biomarker.
Nakano T; Chen CL; Chen IH; Tseng HP; Chiang KC; Lai CY; Hsu LW; Goto S; Lin CC; Cheng YF
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175615
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia-induced exosomes promote hepatocellular carcinoma proliferation and metastasis via miR-1273f transfer.
Yu Y; Min Z; Zhou Zhihang ; Linhong M; Tao R; Yan L; Song H
Exp Cell Res; 2019 Dec; 385(1):111649. PubMed ID: 31562861
[TBL] [Abstract][Full Text] [Related]
27. The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells.
Ma Y; Deng F; Li P; Chen G; Tao Y; Wang H
Biomed Pharmacother; 2018 May; 101():648-655. PubMed ID: 29518611
[TBL] [Abstract][Full Text] [Related]
28. CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling.
Yang L; Xue H; Sun Y; Zhang L; Xue F; Ge R
Cell Death Dis; 2020 Jul; 11(7):605. PubMed ID: 32732872
[TBL] [Abstract][Full Text] [Related]
29. Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells.
Liang G; Kan S; Zhu Y; Feng S; Feng W; Gao S
Int J Nanomedicine; 2018; 13():585-599. PubMed ID: 29430178
[TBL] [Abstract][Full Text] [Related]
30. Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma.
Hu Z; Chen G; Zhao Y; Gao H; Li L; Yin Y; Jiang J; Wang L; Mang Y; Gao Y; Zhang S; Ran J; Li L
Mol Cancer; 2023 Mar; 22(1):55. PubMed ID: 36932387
[TBL] [Abstract][Full Text] [Related]
31. Identification of exosomal hsa-miR-483-5p as a potential biomarker for hepatocellular carcinoma via microRNA expression profiling of tumor-derived exosomes.
Lin J; Lin W; Bai Y; Liao Y; Lin Q; Chen L; Wu Y
Exp Cell Res; 2022 Aug; 417(2):113232. PubMed ID: 35659970
[TBL] [Abstract][Full Text] [Related]
32. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis.
Li ML; Zhang Y; Ma LT
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10708-10720. PubMed ID: 31858580
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2.
Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L
Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978
[TBL] [Abstract][Full Text] [Related]
34. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.
Jin F; Wang Y; Li M; Zhu Y; Liang H; Wang C; Wang F; Zhang CY; Zen K; Li L
Cell Death Dis; 2017 Jan; 8(1):e2540. PubMed ID: 28079894
[TBL] [Abstract][Full Text] [Related]
35. miR-26a promoted by interferon-alpha inhibits hepatocellular carcinoma proliferation and migration by blocking EZH2.
Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y
Genet Test Mol Biomarkers; 2015 Jan; 19(1):30-6. PubMed ID: 25494962
[TBL] [Abstract][Full Text] [Related]
36. CAF-Released Exosomal miR-20a-5p Facilitates HCC Progression via the LIMA1-Mediated β-Catenin Pathway.
Qi Y; Wang H; Zhang Q; Liu Z; Wang T; Wu Z; Wu W
Cells; 2022 Nov; 11(23):. PubMed ID: 36497115
[TBL] [Abstract][Full Text] [Related]
37. Exosome-Mediated MiR-155 Transfer Contributes to Hepatocellular Carcinoma Cell Proliferation by Targeting PTEN.
Sun JF; Zhang D; Gao CJ; Zhang YW; Dai QS
Med Sci Monit Basic Res; 2019 Oct; 25():218-228. PubMed ID: 31645540
[TBL] [Abstract][Full Text] [Related]
38. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway.
Lou G; Chen L; Xia C; Wang W; Qi J; Li A; Zhao L; Chen Z; Zheng M; Liu Y
J Exp Clin Cancer Res; 2020 Jan; 39(1):4. PubMed ID: 31898515
[TBL] [Abstract][Full Text] [Related]
39. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma.
Shi M; Jiang Y; Yang L; Yan S; Wang YG; Lu XJ
J Cell Biochem; 2018 Jun; 119(6):4711-4716. PubMed ID: 29278659
[TBL] [Abstract][Full Text] [Related]
40. Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma.
You LN; Tai QW; Xu L; Hao Y; Guo WJ; Zhang Q; Tong Q; Zhang H; Huang WK
Cancer Gene Ther; 2021 Jun; 28(6):719-736. PubMed ID: 33414518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]